BROOKLYN MILLER: Open Payments
NPI 1831957141 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 56 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,248 · 2025 $1,379
Food & beverage: $1,379
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $227 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $183 |
| ABBVIE INC. | 10 | $168 |
| Incyte Corporation | 2 | $155 |
| Janssen Biotech, Inc. | 8 | $151 |
| Organon LLC | 7 | $110 |
| Lilly USA, LLC | 5 | $108 |
| Amgen Inc. | 4 | $77 |
| GENZYME CORPORATION | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
Products named: Bimzelx, OPZELURA, TREMFYA, Winlevi, RINVOQ, OTEZLA, DUPIXENT, SKYRIZI.
Industry payments across IA — which companies pay providers there.
